Research and innovation news

Advances in technology and data from pacemakers are alerting Manchester doctors of heart failure patients who may benefit from medical attention.

A new trial opens in Greater Manchester today which is to test cutting-edge wearable technologies involving patients who have received cancer treatment.

MFT joins a growing group of like-minded organisations working together to realise the benefits of using health data for research and innovation for public benefit.

Ground-breaking research taking place at Manchester University NHS Foundation Trust is investigating a pioneering new treatment for COVID-19.

MFT has joined global partners as part of the Smart Hospital Alliance (SHA) to drive the expansion of cutting-edge digital health technologies for the benefit of our patients and communities.

The first results of an early trial of a multivariant COVID-19 vaccine booster, launched in Manchester in September 2021, has shown it is driving a comprehensive immune response.

A trainee surgeon at Manchester Royal Infirmary (MRI) was recently awarded a prestigious national honour for his contributions to transplant research.

People who were hospitalised with COVID-19 and continued to experience symptoms at five months show limited further recovery one year after hospital discharge, according to latest research.